Ivernol Cream contains Ivermectin 1% w/w, a broad-spectrum antiparasitic agent indicated for the topical treatment of various parasitic skin infections, including rosacea and demodex mite infestations. Ivermectin acts by binding selectively to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and death of the parasite. This cream formulation is intended for external use and is applied once daily to the affected area, ensuring thorough coverage while avoiding contact with eyes and mucous membranes. Clinical studies have demonstrated its efficacy in reducing inflammatory lesions and erythema associated with rosacea, as well as eradicating demodex mites, thereby improving skin condition and patient comfort. Ivernol Cream is generally well tolerated, with mild and transient adverse effects such as burning, stinging, or dryness at the application site. It is contraindicated in patients with known hypersensitivity to ivermectin or any excipients in the formulation. Use during pregnancy and lactation should be under medical supervision. Patients are advised to follow prescribed instructions carefully and consult a healthcare professional if symptoms persist or worsen.